Technical Feasibility for an Early Cannulation Vascular Access Graft with SLF(TM) Technology

Vascular Flow Technologies旨在通过为透析患者开发可能的最佳治疗方法，在螺旋层流血管通路移植物成功的基础上再接再厉。* * 早期插管入路移植物的开发结合专利螺旋层流技术将允许移植物在植入后立即使用 **。通过开发内部端到端制造，Vascular Flow Technologies将牢固地确立自己作为领先的血管移植物制造商的地位，其工厂位于英国。** 项目的第一阶段 ** 将解决技术可行性问题，探索制造设计方案，并评估新的和现有的技术。** 该项目的第2阶段 ** 将最终导致Vascular Flow Technologies建立全面的膨胀聚四氟乙烯（ePTFE）移植物制造，利用现有资产并建立长期供应链安全。

Vascular Flow Technologies intend to build on the success of the Spiral Laminar Flow Vascular Access Graft by developing the best treatment possible for dialysis patients. The development of an **Early Cannulation Access Graft coupled with the patented Spiral Laminar Flow technology will allow immediate use of the graft post implantation**. By developing in-house end-to-end manufacturing, Vascular Flow Technologies will firmly establish itself as a leading vascular graft manufacturer with facilities based in the UK. **Phase 1** of the project will address the technical feasibility and explore design for manufacture options and evaluate new and existing technologies. **Phase 2** of the project will ultimately lead to Vascular Flow Technologies setting up full scale expanded polytetraflurorethylene (ePTFE) graft manufacturing, capitalising on existing assets and creating long term supply chain security.